# Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer

> **NCT00003972** · PHASE3 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 280 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** sargramostim
- **DRUG:** busulfan
- **DRUG:** carboplatin
- **DRUG:** cyclophosphamide
- **DRUG:** melphalan
- **DRUG:** paclitaxel
- **DRUG:** tamoxifen citrate
- **DRUG:** thiotepa
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003972
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-07
- **Primary completion:** 2003-03
- **Final completion:** 2003-03
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2010-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003972, "Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00003972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*